1
Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors
Condition(s):Solid and Hematological MalignanciesLast Updated:January 7, 2021Terminated
T Cell Receptor: 1790 Clinical Trials, Page 1 of 179
Hide Studies Not Open or Pending
2
Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
Condition(s):Squamous Lntraepithelial Lesions of Vulva; Neoplasms, Squamous Cell; Vulvar HSILLast Updated:April 13, 2021Terminated
3
Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
Condition(s):Human Papillomavirus; HPV-16; High Grade Squamous Intraepithelial LesionLast Updated:February 16, 2021Terminated
4
E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer
Condition(s):Uterine Cervical NeoplasmsLast Updated:December 15, 2021Terminated
5
E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer
Condition(s):Papillomavirus Infections; Oropharyngeal NeoplasmsLast Updated:February 24, 2022Terminated
6
T-cell Receptor α/β Depleted Donor Lymphocyte Infusion
Condition(s):Lymphoid Leukemia, Acute; Myeloid Malignancy; Plasma Cell TumorLast Updated:May 23, 2023Recruiting
7
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Condition(s):Vaginal Cancer; Cervical Cancer; Anal Cancer; Penile Cancer; Oropharyngeal CancerLast Updated:September 6, 2017Completed
8
Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
Condition(s):Malignant Epithelial NeoplasmsLast Updated:August 1, 2023Active, not recruiting
9
T Cell Receptor Based Therapy of Metastatic Colorectal Cancer
Condition(s):Colorectal CancerLast Updated:June 13, 2019Terminated
10
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:April 7, 2020Unknown status